recombinant modified-C reactive protein (Immtech)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namerecombinant modified-C reactive protein (Immtech)
Drug Alias Namer(m)CRP (NextEra)r(m)CRP (Immtech)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNextera Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNextera TherapeuticsImmtech Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A